Skip to content

Metabolic Changes Induced by Genetically Modified Potatoes

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00953966
Enrollment
50
Registered
2009-08-06
Start date
2007-06-30
Completion date
2009-12-31
Last updated
2009-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endocrine Metabolism, Glucose Metabolism, Satiety

Brief summary

Starches from genetically modified potatoes, which differed in terms of amylose, amylopectin and phosphate content, were tested in a human randomized controlled trial.

Interventions

OTHERGenetically modified potatoes

Starch from genetically modified potatoes

Sponsors

Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
MALE
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy males

Exclusion criteria

* no acute oder severe chronic diseases

Design outcomes

Primary

MeasureTime frame
Glucose metabolism2 days

Countries

Germany

Contacts

Primary ContactJoachim Spranger, MD
joachim.spranger@charite.de0049308445

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026